Close Menu

Biodesix

NEW YORK (GenomeWeb News) – Pacific Biosciences has appointed Jonas Korlach to chief scientific officer, a position previously held by Eric Schadt, who will remain a key scientific advisor to the company.

Quanterix announced this week it has appointed Paul Chapman as its new president and CEO, replacing Martin Madaus, who will continue at the company as executive chairman.

Biodesix this week presented data indicating that a proteomic signature identified using the company's ProTS mass spec-based system can identify pancreatic cancer patients likely to respond to treatment with GlobeImmune's GI-4000 therapy.

Biodesix last week presented results from a combined analysis of two Phase II trials using its Veristrat lung cancer companion diagnostic.

By Adam Bonislawski
Biodesix said this week that it is collaborating with pharma firm Kadmon on a 620-patient Phase III clinical trial of that company's reversible tyrosine kinase inhibitor KD019.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Gen-Probe disclosed in its annual 2011 earnings document that it has lost almost $41 million in its investment in Pacific Biosciences as of the end of 2011.

By Tony Fong
NEW YORK (GenomeWeb News) – Biodesix is progressing on its plans to partner with pharmaceutical and biotechnology firms to drive adoption of its VeriStrat test, a company official told GenomeWeb Daily News last week.

This story originally ran on Dec. 13.
Biodesix last week presented results from a retrospective analysis of breast cancer patients using its serum proteomic Veristrat diagnostic.

A study published this month in the Journal of Thoracic Oncology supports the usefulness of Biodesix's VeriStrat lung cancer diagnostic in monitori

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.